45 related articles for article (PubMed ID: 11179834)
1. Expressions of cancer-testis antigens in human hepatocellular carcinomas.
Chen CH; Chen GJ; Lee HS; Huang GT; Yang PM; Tsai LJ; Chen DS; Sheu JC
Cancer Lett; 2001 Mar; 164(2):189-95. PubMed ID: 11179834
[TBL] [Abstract][Full Text] [Related]
2. Molecular and immunological evaluation of the expression of cancer/testis gene products in human colorectal cancer.
Alves PM; Lévy N; Bouzourene H; Viatte S; Bricard G; Ayyoub M; Vuilleumier H; Givel JC; Halkic N; Speiser DE; Romero P; Lévy F
Cancer Immunol Immunother; 2007 Jun; 56(6):839-47. PubMed ID: 16960690
[TBL] [Abstract][Full Text] [Related]
3. Identification of immunoglobulin superfamily 11 (IGSF11) as a novel target for cancer immunotherapy of gastrointestinal and hepatocellular carcinomas.
Watanabe T; Suda T; Tsunoda T; Uchida N; Ura K; Kato T; Hasegawa S; Satoh S; Ohgi S; Tahara H; Furukawa Y; Nakamura Y
Cancer Sci; 2005 Aug; 96(8):498-506. PubMed ID: 16108831
[TBL] [Abstract][Full Text] [Related]
4. Novel Nanotechnology Approaches to Overcome Drug Resistance in the Treatment of Hepatocellular Carcinoma: Glypican 3 as a Useful Target for Innovative Therapies.
Mossenta M; Busato D; Dal Bo M; Macor P; Toffoli G
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077433
[TBL] [Abstract][Full Text] [Related]
5. Meiotic Genes and DNA Double Strand Break Repair in Cancer.
Lingg L; Rottenberg S; Francica P
Front Genet; 2022; 13():831620. PubMed ID: 35251135
[TBL] [Abstract][Full Text] [Related]
6. CD8
Hofmann M; Tauber C; Hensel N; Thimme R
J Clin Med; 2021 Mar; 10(5):. PubMed ID: 33801203
[TBL] [Abstract][Full Text] [Related]
7. Tumor-associated autoantibodies in combination with alpha-fetoprotein for detection of early stage hepatocellular carcinoma.
Welberry C; Macdonald I; McElveen J; Parsy-Kowalska C; Allen J; Healey G; Irving W; Murray A; Chapman C
PLoS One; 2020; 15(5):e0232247. PubMed ID: 32374744
[TBL] [Abstract][Full Text] [Related]
8. Inefficient induction of circulating TAA-specific CD8+ T-cell responses in hepatocellular carcinoma.
Tauber C; Schultheiss M; Luca R; Buettner N; Llewellyn-Lacey S; Emmerich F; Zehe S; Price DA; Neumann-Haefelin C; Schmitt-Graeff A; Hofmann M; Thimme R
Oncotarget; 2019 Aug; 10(50):5194-5206. PubMed ID: 31497249
[No Abstract] [Full Text] [Related]
9. Combined cancer testis antigens enhanced prediction accuracy for prognosis of patients with hepatocellular carcinoma.
Wang M; Li J; Wang L; Chen X; Zhang Z; Yue D; Ping Y; Shi X; Huang L; Zhang T; Yang L; Zhao Y; Ma X; Li D; Fan Z; Zhao L; Tang Z; Zhai W; Zhang B; Zhang Y
Int J Clin Exp Pathol; 2015; 8(4):3513-28. PubMed ID: 26097535
[TBL] [Abstract][Full Text] [Related]
10. Tumour antigen expression in hepatocellular carcinoma in a low-endemic western area.
Sideras K; Bots SJ; Biermann K; Sprengers D; Polak WG; IJzermans JN; de Man RA; Pan Q; Sleijfer S; Bruno MJ; Kwekkeboom J
Br J Cancer; 2015 Jun; 112(12):1911-20. PubMed ID: 26057582
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma patients highly and specifically expressing XAGE-1 exhibit prolonged survival.
Gong L; Peng J; Cui Z; Chen P; Han H; Zhang D; Leng X
Oncol Lett; 2010 Nov; 1(6):1083-1088. PubMed ID: 22870117
[TBL] [Abstract][Full Text] [Related]
12. NY-ESO-1 expression in hepatocellular carcinoma: A potential new marker for early recurrence after surgery.
Xu H; Gu N; Liu ZB; Zheng M; Xiong F; Wang SY; Li N; Lu J
Oncol Lett; 2012 Jan; 3(1):39-44. PubMed ID: 22740853
[TBL] [Abstract][Full Text] [Related]
13. Downstream and intermediate interactions of synovial sarcoma-associated fusion oncoproteins and their implication for targeted therapy.
Przybyl J; Jurkowska M; Rutkowski P; Debiec-Rychter M; Siedlecki JA
Sarcoma; 2012; 2012():249219. PubMed ID: 22550415
[TBL] [Abstract][Full Text] [Related]
14. The biology of cancer testis antigens: putative function, regulation and therapeutic potential.
Fratta E; Coral S; Covre A; Parisi G; Colizzi F; Danielli R; Nicolay HJ; Sigalotti L; Maio M
Mol Oncol; 2011 Apr; 5(2):164-82. PubMed ID: 21376678
[TBL] [Abstract][Full Text] [Related]
15. The SSX family of cancer-testis antigens as target proteins for tumor therapy.
Smith HA; McNeel DG
Clin Dev Immunol; 2010; 2010():150591. PubMed ID: 20981248
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of cancer-testis antigen mRNA in peripheral blood from hepatocellular carcinoma patients.
Zhao L; Mou DC; Peng JR; Huang L; Wu ZA; Leng XS
World J Gastroenterol; 2010 Aug; 16(32):4072-8. PubMed ID: 20731022
[TBL] [Abstract][Full Text] [Related]
17. Strong CD8(+) T-cell responses against tumor-associated antigens prolong the recurrence-free interval after tumor treatment in patients with hepatocellular carcinoma.
Hiroishi K; Eguchi J; Baba T; Shimazaki T; Ishii S; Hiraide A; Sakaki M; Doi H; Uozumi S; Omori R; Matsumura T; Yanagawa T; Ito T; Imawari M
J Gastroenterol; 2010 Apr; 45(4):451-8. PubMed ID: 19936602
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy for liver tumors: present status and future prospects.
Matar P; Alaniz L; Rozados V; Aquino JB; Malvicini M; Atorrasagasti C; Gidekel M; Silva M; Scharovsky OG; Mazzolini G
J Biomed Sci; 2009 Mar; 16(1):30. PubMed ID: 19272130
[TBL] [Abstract][Full Text] [Related]
19. Assessment of CD4+ T cells specific for the tumor antigen SSX-1 in cancer-free individuals.
Godefroy E; Wang Y; Souleimanian NE; Scotto L; Stevanovic S; Chen YT; Valmori D; Ayyoub M
Cancer Immunol Immunother; 2007 Aug; 56(8):1183-92. PubMed ID: 17186289
[TBL] [Abstract][Full Text] [Related]
20. Expression of cancer-testis antigens in hepatocellular carcinoma.
Zhao L; Mou DC; Leng XS; Peng JR; Wang WX; Huang L; Li S; Zhu JY
World J Gastroenterol; 2004 Jul; 10(14):2034-8. PubMed ID: 15237429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
